By Jeanne Lenzer, Medical Investigative Journalist Merck’s promotion of Gardasil, its vaccine against the human papilloma virus (HPV), has a complicated history. First there was the exuberant claim about its reputedly great effectiveness in preventing cervical cancer. Now comes the recommendation last month from the Centers for Disease Control and Prevention, that all 11- and 12-year-old boys should […]
QIAGEN Reaches Milestone With 75 Million Deliveries of HPV Tests, Announces Strategy Update for QIAensemble Program
HILDEN, Germany and GERMANTOWN, Maryland, May 8, 2011 /PRNewswire/ — – Growing U.S. market penetration and other regions’ adoption of HPV testing in cervical cancer screening programs drive global deliveries of digene HC2 HPV Test – digene HC2 HPV Test remains the “gold standard” in screening women for risk of cervical cancer based on clinical […]
Conflicts of Interest in the Losing Cancer War
Posted by Norma Erickson, SaneVax 15 September 2010 This article was written by Samuel S. Epstein, MD, Chairman of the Cancer Prevention Coalition, and Quentin D. Young, MD, Chairman of the Health and Medicine Policy Research Group. Although it was originally published on 4 March 2004, the information contained within is still timely. It […]
